Correlative outcomes of maternal immunization against RSV in cotton rats

References

• Shi T, McAllister DA, O’Brien KL, Simoes EAF, Madhi SA, Gessner BD, Polack FP, Balsells E, Acacio S, Aguayo C, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017 Sep 2;390(10098):946–13. doi:10.1016/S0140-6736(17)30938-8. Epub 2017 Jul 7. PMID: 28689664.
   PubMed Web of Science ®Google Scholar
• McLaughlin JM, Khan F, Begier E, Swerdlow DL, Jodar L, Falsey AR. Rates of medically attended RSV among US adults: a systematic review and meta-analysis. Open Forum Infect Dis. 2022 Jun 17;9(7):ofac300. doi:10.1093/ofid/ofac300. PMID: 35873302.
   PubMed Web of Science ®Google Scholar
• McGinley JP, Lin GL, Öner D, Golubchik T, O’Connor D, Snape MD, Gruselle O, Langedijk AC, Wildenbeest J, Openshaw P, et al., RESCEU Investigators. Clinical and viral factors associated with disease severity and subsequent wheezing in infants with respiratory syncytial virus infection. J Infect Dis. 2022 Aug 12;226(Suppl 1):S45–54. doi:10.1093/infdis/jiac163. PMID: 35902389.
   PubMed Web of Science ®Google Scholar
• van Wijhe M, Johannesen CK, Simonsen L, Jørgensen IM, Fischer TK, Campbell H, Beutels P, Bont L, Pollard A, Openshaw P, et al. A retrospective cohort study on infant respiratory tract infection hospitalizations and recurrent wheeze and asthma risk: impact of respiratory syncytial virus. J Infect Dis. 2022 Aug 12;226(Suppl 1):S55–62. doi:10.1093/infdis/jiac141. PMID: 35426942.
   PubMed Web of Science ®Google Scholar
• Wang X, Li Y, Nair H, Campbell H, Wang X, Reeves RM, Li Y, Campbell H, Nair H, van Wijhe M, et al., RESCEU Insvestigators. Time-Varying association between severe respiratory syncytial virus infections and subsequent severe asthma and wheeze and influences of age at the infection. J Infect Dis. 2022 Aug 12;226(Suppl 1):S38–44. doi:10.1093/infdis/jiab308. PMID: 34522963.
   PubMed Web of Science ®Google Scholar
• The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998 Sep;102(3 Pt 1):531–37. doi:10.1542/peds.102.3.531. PMID: 9738173.
   Web of Science ®Google Scholar
• Hammitt LL, Dagan R, Yuan Y, Baca Cots M, Bosheva M, Madhi SA, Muller WJ, Zar HJ, Brooks D, Grenham A, et al. Nirsevimab for prevention of RSV in healthy late-preterm and term infants. N Engl J Med. 2022 Mar 3;386(9):837–46. doi:10.1056/NEJMoa2110275. PMID: 35235726.
   PubMed Web of Science ®Google Scholar
• Kapikian AZ, Mitchell RH, Chanock RM, Shvedoff RA, Stewart CE An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol. 1969 Apr;89(4):405–21. doi:10.1093/oxfordjournals.aje.a120954. PMID: 4305197.
   PubMed Web of Science ®Google Scholar
• Chin J, Magoffin RL, Shearer LA, Schieble JH, Lennette EH Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol. 1969 Apr;89(4):449–63. doi:10.1093/oxfordjournals.aje.a120957. PMID: 4305200.
   PubMed Web of Science ®Google Scholar
• Fulginiti VA, Eller JJ, Sieber OF, Joyner JW, Minamitani M, Meiklejohn G Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am J Epidemiol. 1969 Apr;89(4):435–48. doi:10.1093/oxfordjournals.aje.a120956. PMID: 4305199.
   PubMed Web of Science ®Google Scholar
• Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K, Parrott RH Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol. 1969 Apr;89(4):422–34. doi:10.1093/oxfordjournals.aje.a120955. PMID: 4305198.
   PubMed Web of Science ®Google Scholar
• Mazur NI, Terstappen J, Baral R, Bardají A, Beutels P, Buchholz UJ, Cohen C, Crowe JE Jr, Cutland CL, Eckert L, et al. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. Lancet Infect Dis. 2022 Aug 8;S1473-3099(22):00291–2. doi:10.1016/S1473-3099(22)00291-2. Epub ahead of print. PMID: 35952703.
   Google Scholar
• Etti M, Calvert A, Galiza E, Lim S, Khalil A, Le Doare K, Heath PT Maternal vaccination: a review of current evidence and recommendations. Am J Obstet Gynecol. 2022 Apr;226(4):459–74. doi:10.1016/j.ajog.2021.10.041. Epub 2021 Nov 11. PMID: 34774821.
   PubMed Web of Science ®Google Scholar
• Chu HY, Englund JA. Maternal immunization. Birth Defects Res. 2017 Mar 15;109(5):379–86. doi:10.1002/bdra.23547. PMID: 28398678.
   PubMedGoogle Scholar
• Stensballe LG, Fullarton JR, Carbonell-Estrany X, Simões EA Population based external validation of a European predictive model for respiratory syncytial virus hospitalization of premature infants born 33 to 35 weeks of gestational age. Pediatr Infect Dis J. 2010 Apr;29(4):374–76. doi:10.1097/INF.0b013e3181c810da. PMID: 20016397.
   PubMed Web of Science ®Google Scholar
• Chu HY, Tielsch J, Katz J, Magaret AS, Khatry S, LeClerq SC, Shrestha L, Kuypers J, Steinhoff MC, Englund JA. Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal. J Clin Virol. 2017 Oct;95:90–95. doi:10.1016/j.jcv.2017.08.017. Epub 2017 Sep 2. PMID: 28903080.
   PubMed Web of Science ®Google Scholar
• Ogilvie MM, Vathenen AS, Radford M, Codd J, Key S. Maternal antibody and respiratory syncytial virus infection in infancy. J Med Virol. 1981;7(4):263–71. doi:10.1002/jmv.1890070403. PMID: 7038043.
   PubMed Web of Science ®Google Scholar
• Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr. 1981 May;98(5):708–15. doi:10.1016/s0022-3476(81)80829-3. PMID: 7229749.
   PubMed Web of Science ®Google Scholar
• Lamprecht CL, Krause HE, Mufson MA Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus. J Infect Dis. 1976 Sep;134(3):211–17. doi:10.1093/infdis/134.3.211. PMID: 977992.
   PubMed Web of Science ®Google Scholar
• Blanco JCG, Cullen LM, Kamali A, Sylla FYD, Boukhvalova MS, Morrison TG, Bukreyev A. Evolution of protection after maternal immunization for respiratory syncytial virus in cotton rats. PLoS Pathog. 2021 Dec 23;17(12):e1009856. doi:10.1371/journal.ppat.1009856. PMID: 34941963.
   PubMed Web of Science ®Google Scholar
• Murawski MR, McGinnes LW, Finberg RW, Kurt-Jones EA, Massare MJ, Smith G, Heaton PM, Fraire AE, Morrison TG Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology. J Virol. 2010 Jan;84(2):1110–23. doi:10.1128/JVI.01709-09. Epub 2009 Nov 4. PMID: 19889768.
   PubMed Web of Science ®Google Scholar
• Morrison TG, Gravel KA, Finberg RW, Kurt-Jones EA, Massare MJ, Smith G, Schmidt MR, Morrison TG. Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins. J Virol. 2011 Jan;85(1):366–77. doi:10.1128/JVI.01861-10. Epub 2010 Oct 27. PMID: 20980510.
   PubMed Web of Science ®Google Scholar
• McGinnes Cullen L, Schmidt MR, Kenward SA, Woodland RT, Morrison TG, Lyles DS. Murine immune responses to virus-like particle-associated pre- and postfusion forms of the respiratory syncytial virus F protein. J Virol. 2015 Jul;89(13):6835–47. doi:10.1128/JVI.00384-15. Epub 2015 Apr 22. PMID: 25903340.
   PubMed Web of Science ®Google Scholar
• McLellan JS, Chen M, Leung S, Graepel KW, Du X, Yang Y, Zhou T, Baxa U, Yasuda E, Beaumont T, et al. Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science. 2013 May 31;340(6136):1113–17. doi:10.1126/science.1234914. Epub 2013 Apr 25. PMID: 23618766.
   PubMed Web of Science ®Google Scholar
• Krarup A, Truan D, Furmanova-Hollenstein P, Bogaert L, Bouchier P, Bisschop IJM, Widjojoatmodjo MN, Zahn R, Schuitemaker H, McLellan JS, et al. A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism. Nat Commun. 2015 Sep 3;6(1):8143. doi:10.1038/ncomms9143. PMID: 26333350
   PubMedGoogle Scholar
• Blanco JCG, Fernando LR, Zhang W, Kamali A, Boukhvalova MS, McGinnes-Cullen L, Morrison TG, Dutch RE. Alternative virus-like particle-associated prefusion F proteins as maternal vaccines for respiratory syncytial virus. J Virol. 2019 Nov 13;93(23):e00914–19. doi:10.1128/JVI.00914-19. PMID: 31511382
   PubMed Web of Science ®Google Scholar
• McGinnes LW, Morrison TG. Newcastle disease virus-like particles: preparation, purification, quantification, and incorporation of foreign glycoproteins. Curr Protoc Microbiol. 2013 Oct 2;30(1):18.2.1–18.2.21. doi:10.1002/9780471729259.mc1802s30. PMID: 24510891.
   PubMedGoogle Scholar
• Blanco JCG, Pletneva LM, McGinnes-Cullen L, Otoa RO, Patel MC, Fernando LR, Boukhvalova MS, Morrison TG. Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model. Nat Commun. 2018 May 15;9(1):1904. doi:10.1038/s41467-018-04216-6. PMID: 29765035.
   PubMedGoogle Scholar
• Cullen LM, Schmidt MR, Torres GM, Capoferri AA, Morrison TG. Comparison of immune responses to different versions of VLP associated stabilized RSV pre-fusion F protein. Vaccines (Basel). 2019 Feb 15;7(1):21. doi:10.3390/vaccines7010021. PMID: 30769923.
   PubMed Web of Science ®Google Scholar
• Coates HV, Alling DW, Chanock RM An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test. Am J Epidemiol. 1966 Mar;83(2):299–313. doi:10.1093/oxfordjournals.aje.a120586. PMID: 5933417.
   PubMed Web of Science ®Google Scholar
• Prince GA, Prieels JP, Slaoui M, Porter DD. Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat (Sigmodon hispidus). Lab Invest. 1999 Nov;79(11):1385–92. PMID: 10576209.
   PubMed Web of Science ®Google Scholar
• Wang X, Li Y, Vazquez Fernandez L, Teirlinck AC, Lehtonen T, van Wijhe M, Stona L, Bangert M, Reeves RM, Bøås H, et al. Respiratory syncytial virus-associated hospital admissions and bed days in children <5 years of age in 7 European countries. J Infect Dis. 2022 Aug 12;226(Suppl 1):S22–28. doi:10.1093/infdis/jiab560. PMID: 35023567.
   PubMed Web of Science ®Google Scholar
• Baral R, Li X, Willem L, Antillon M, Vilajeliu A, Jit M, Beutels P, Pecenka C. The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: estimates from two models. Vaccine. 2020 Jul 14;38(33):5139–47. doi:10.1016/j.vaccine.2020.06.036. Epub 2020 Jun 22. PMID: 32586761; PMCID: PMC7342012.
   PubMed Web of Science ®Google Scholar
• Blanco JCG, Pletneva LM, Otoa RO, Patel MC, Vogel SN, Boukhvalova MS. Preclinical assessment of safety of maternal vaccination against respiratory syncytial virus (RSV) in cotton rats. Vaccine. 2017 Jul 13;35(32):3951–58. doi:10.1016/j.vaccine.2017.06.009. Epub 2017 Jun 16. PMID: 28624306.
   PubMed Web of Science ®Google Scholar
• Blanco JCG, Pletneva LM, Oue RO, Patel MC, Boukhvalova MS. Maternal transfer of RSV immunity in cotton rats vaccinated during pregnancy. Vaccine. 2015 Oct 5;33(41):5371–79. doi:10.1016/j.vaccine.2015.08.071. Epub 2015 Aug 31. PMID: 26335771.
   PubMed Web of Science ®Google Scholar
• Nyiro JU, Bukusi E, Mwaengo D, Nyaguara A, Nyawanda B, Otieno N, Bigogo G, Murunga N, Widdowson MA, Verani JR, et al. Efficiency of transplacental transfer of respiratory syncytial virus (RSV) specific antibodies among pregnant women in Kenya. Wellcome Open Res. 2022 Apr 1;7:43. doi:10.12688/wellcomeopenres.17636.2. PMID: 35402734.
   PubMedGoogle Scholar
• Blanco JC, Richardson JY, Darnell ME, Rowzee A, Pletneva L, Porter DD, Prince GA. Cytokine and chemokine gene expression after primary and secondary respiratory syncytial virus infection in cotton rats. J Infect Dis. 2002 Jun 15;185(12):1780–85. doi:10.1086/340823. Epub 2002 May 31. PMID: 12085325.
   PubMed Web of Science ®Google Scholar
• Mejías A, Chávez-Bueno S, Raynor MB, Connolly J, Kiener PA, Jafri HS, Ramilo O. Motavizumab, a neutralizing anti-Respiratory Syncytial Virus (Rsv) monoclonal antibody significantly modifies the local and systemic cytokine responses induced by Rsv in the mouse model. Virol J. 2007 Oct 25;4(1):109. doi:10.1186/1743-422X-4-109. PMID: 17961258.
   PubMedGoogle Scholar
• Mukherjee S, Lindell DM, Berlin AA, Morris SB, Shanley TP, Hershenson MB, Lukacs NW IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Am J Pathol. 2011 Jul;179(1):248–58. doi:10.1016/j.ajpath.2011.03.003. Epub 2011 May 3. PMID: 21703407.
   PubMed Web of Science ®Google Scholar
• Faber TE, Groen H, Welfing M, Jansen KJ, Bont LJ Specific increase in local IL-17 production during recovery from primary RSV bronchiolitis. J Med Virol. 2012 Jul;84(7):1084–88. doi:10.1002/jmv.23291. PMID: 22585726.
   PubMed Web of Science ®Google Scholar
• Bennett BL, Garofalo RP, Cron SG, Hosakote YM, Atmar RL, Macias CG, Piedra PA. Immunopathogenesis of respiratory syncytial virus bronchiolitis. J Infect Dis. 2007 May 15;195(10):1532–40. doi:10.1086/515575. Epub 2007 Apr 12. PMID: 17436234.
   PubMed Web of Science ®Google Scholar
• Bukreyev A, Whitehead SS, Bukreyeva N, Murphy BR, Collins PL. Interferon gamma expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity. Proc Natl Acad Sci USA. 1999 Mar 2;96(5):2367–72. doi:10.1073/pnas.96.5.2367. PMID: 10051648.
   PubMed Web of Science ®Google Scholar
• Pyle CJ, Uwadiae FI, Swieboda DP, Harker JA, Lopez CB. Early IL-6 signalling promotes IL-27 dependent maturation of regulatory T cells in the lungs and resolution of viral immunopathology. PLoS Pathog. 2017 Sep 27;13(9):e1006640. doi:10.1371/journal.ppat.1006640. PMID: 28953978.
   PubMed Web of Science ®Google Scholar
• Besteman SB, Phung E, Raeven HHM, Amatngalim GD, Rumpret M, Crabtree J, Schepp RM, Rodenburg LW, Siemonsma SG, Verleur N, et al. Recurrent respiratory syncytial virus infection in a CD14-Deficient patient. J Infect Dis. 2022 Aug 24;226(2):258–69. doi:10.1093/infdis/jiac114. PMID: 35429403; PMCID: PMC9400420.
   PubMed Web of Science ®Google Scholar
• Eichinger KM, Kosanovich JL, Lipp MA, Perkins TN, Petrovsky N, Marshall C, Yondola MA, Empey KM. Maternal immunization with adjuvanted RSV prefusion F protein effectively protects offspring from RSV challenge and alters innate and T cell immunity. Vaccine. 2020 Nov 25;38(50):7885–91. doi:10.1016/j.vaccine.2020.10.065. Epub 2020 Oct 29. PMID: 33129608.
   PubMed Web of Science ®Google Scholar
• Orije MRP, Maertens K, Corbière V, Wanlapakorn N, Van Damme P, Leuridan E, Mascart F. The effect of maternal antibodies on the cellular immune response after infant vaccination: a review. Vaccine. 2020 Jan 3;38(1):20–28. doi:10.1016/j.vaccine.2019.10.025. Epub 2019 Oct 28. PMID: 31672332.
   PubMed Web of Science ®Google Scholar